Abstract
Hepatocellular carcinoma (HCC) has the tendency to invade the portal and/or hepatic venous system. The invasion of the right atrium is uncommonly observed and constitutes a treatment challenge. We report the case of a patient with HCC invading the right atrium treated with 90Yttrium-transarterial radioembolization (90Y-TARE). Following the treatment, organizing pneumonia secondary to nivolumab occurred, raising the question of an interaction between 90Y-TARE and nivolumab.
Highlights
Data about the treatment of hepatocellular carcinoma (HCC) invading the right atrium is scarce
We report the case of a patient with Hepatocellular carcinoma (HCC) invading the right atrium treated with 90Yttrium-transarterial radioembolization (90Y-TARE)
We report the case of a patient with HCC invading the right atrium who benefited from 90Yttrium-transarterial radioembolization (90Y-TARE)
Summary
We report the case of a patient with HCC invading the right atrium treated with 90Yttrium-transarterial radioembolization (90Y-TARE). Data about the treatment of hepatocellular carcinoma (HCC) invading the right atrium is scarce. We report the case of a patient with HCC invading the right atrium who benefited from 90Yttrium-transarterial radioembolization (90Y-TARE).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
